OCEAN was an open-label trial conducted in Australia, Belgium, Canada, China, Germany, and Israel. Eligible participants had ...

The drug targets the PCSK9 protein, and could give millions of people a more affordable option to reduce their heart disease ...

One dose of an experimental drug cover offer lifetime treatment for people with high cholesterol, but its long-term safety is ...

An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers ...

An experimental gene-editing treatment shows promise for permanently lowering levels of cholesterol and triglycerides, ...

NEW ORLEANS – A single injection of a gene-edited protein was deemed productive and safe in patients with dyslipidemia that ...

If someone went into cardiac arrest in front of you, would you know how to save them? That’s a question a local girl and the ...

The Mobile Heart Walk was held Saturday morning on campus. Dozens of people gathered on the campus for the event. Fox Ten is the media sponsor and Lenise Ligon and other FOX 10 staff members were on ...

For some people with high cholesterol, making lifestyle changes and taking routine cholesterol-lowering statin medications ...

Students at Sunset Mesa Elementary raised more than $30,000 for the American Heart Association. For the fifth year in a row, ...

A new study found that your score on a key cardiovascular test may indicate your risk of dying in the coming years — even ...

Amgen's Repatha lowered first heart attacks and strokes by 36% in a major trial, suggesting PCSK9 drugs may prevent acute ...